We demonstrated that the inhibition of PDE5 enzyme activity potentiated EGCG-induced apoptotic cell death with a physiological concentration of EGCG (5 μM) via the activation of the eNOS/cGMP/PKCδ signaling pathway in colon cancer cells. This evidence concerns the gene PDE5A and colonic neoplasm.